These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24944609)

  • 1. Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.
    Lin J; Zhou J; Xu W; Hong Z; Peng J
    Exp Ther Med; 2014 Jul; 8(1):118-124. PubMed ID: 24944609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.
    Lin J; Zhou J; Xu W; Zhong X; Hong Z; Peng J
    Exp Ther Med; 2013 May; 5(5):1293-1300. PubMed ID: 23737867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X; Lin J; Zhou J; Xu W; Hong Z
    Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
    Zheng H; Xu W; Lin J; Peng J; Hong Z
    Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.
    Lin J; Zhou J; Zhong X; Hong Z; Peng J
    Mol Med Rep; 2015 Mar; 11(3):2207-14. PubMed ID: 25394909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia.
    Liu L; Wan Y; Shen A; Zhao J; Lin J; Zhong X; Zhang Y; Hong Z
    Evid Based Complement Alternat Med; 2015; 2015():365484. PubMed ID: 26294924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
    Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
    J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.
    Hong ZF; Lin JM; Zhong XY; Li Y; Zhou JH; Xu W; Peng J
    Chin J Integr Med; 2012 Nov; 18(11):824-30. PubMed ID: 23086486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
    Zhou J; Lei Y; Chen J; Zhou X
    Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia.
    Jin Cho W; Pyo JS
    Pathol Res Pract; 2020 Jan; 216(1):152694. PubMed ID: 31734054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
    Lekas A; Lazaris AC; Deliveliotis C; Chrisofos M; Zoubouli C; Lapas D; Papathomas T; Fokitis I; Nakopoulou L
    Anticancer Res; 2006; 26(4B):2989-93. PubMed ID: 16886625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
    Wu X; Gu Y; Li L
    Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.
    Berger AP; Kofler K; Bektic J; Rogatsch H; Steiner H; Bartsch G; Klocker H
    Prostate; 2003 Sep; 57(1):57-65. PubMed ID: 12886524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation.
    Kim HJ; Park JW; Cho YS; Cho CH; Kim JS; Shin HW; Chung DH; Kim SJ; Chun YS
    Biochim Biophys Acta; 2013 Jan; 1832(1):183-94. PubMed ID: 22986049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells.
    Yao H; Wang H; Zhang Z; Jiang BH; Luo J; Shi X
    Int J Cancer; 2008 Sep; 123(6):1255-61. PubMed ID: 18561315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
    Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
    Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
    [No Abstract]   [Full Text] [Related]  

  • 17. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
    Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
    Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1α (HIF-1α) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia.
    Chen Y; Xu H; Shi Q; Gu M; Wan X; Chen Q; Wang Z
    Int J Clin Exp Pathol; 2019; 12(1):295-304. PubMed ID: 31933745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.